A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

ClinicalTrials.gov ID: NCT07300969

Public ClinicalTrials.gov record NCT07300969. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Double-blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of DT-101 in Adults With Major Depressive Disorder (MDD)

Study identification

NCT ID: NCT07300969
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Draig Therapeutics Ltd; Industry
Enrollment: 300 participants

Conditions and interventions

Conditions

Major Depressive Disorder (MDD)

Interventions

DT-101 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 75 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 15, 2025
Primary completion: Jul 31, 2027
Completion: Jul 31, 2027
Last update posted: Apr 23, 2026

2025 – 2027

United States locations

U.S. sites: 23
U.S. states: 13
U.S. cities: 22

Facility	City	State	ZIP	Site status
Draig Clinical Site	Bentonville	Arkansas	72712	Recruiting
Draig Clinical Site	Little Rock	Arkansas	72211	Recruiting
Draig Clinical Site	Oceanside	California	92056	Recruiting
Draig Clinical Site	San Diego	California	92103	Recruiting
Draig Clinical Site	Torrance	California	90502	Recruiting
Draig Clinical Site	Miami	Florida	33166	Recruiting
Draig Clinical Site	New Port Richey	Florida	34652	Recruiting
Draig Clinical Site	Orlando	Florida	32803	Recruiting
Draig Clinical Site	Atlanta	Georgia	30331	Recruiting
Draig Clinical Site	Decatur	Georgia	30030	Recruiting
Draig Clinical Site	Gaithersburg	Maryland	20877	Recruiting
Draig Clinical Site	Watertown	Massachusetts	02472	Recruiting
Draig Clinical Site	Flowood	Mississippi	39232	Recruiting
Draig Clinical Site	Las Vegas	Nevada	89102	Recruiting
Draig Clinical Site	Marlton	New Jersey	08009	Recruiting
Draig Clinical Site	New York	New York	10312	Recruiting
Draig Clinical Site	Media	Pennsylvania	19372	Recruiting
Draig Clinical Site	Austin	Texas	78737	Recruiting
Draig Clinical Site	Austin	Texas	78754	Not yet recruiting
Draig Clinical Site	DeSoto	Texas	75115	Recruiting
Draig Clinical Site	Richardson	Texas	75243	Recruiting
Draig Clinical Site	Wichita Falls	Texas	76309	Recruiting
Draig Clinical Site	Bellevue	Washington	98004	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07300969, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 23, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07300969 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →